Beneficial owner of Perspective Therapeutics(CATX)Lantheus purchased 60,431,039 shares of company stock at 95c per share for a total transaction amount of $57,409,487
Company Profile
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based...